CVE:GSD Devonian Health Group (GSD) Stock Price, News & Analysis C$8.95 0.00 (0.00%) As of 09/22/2026 03:19 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartNews and Trends About Devonian Health Group Stock (CVE:GSD) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Devonian Health Group alerts:Sign Up Key Stats Today's RangeC$8.25▼C$8.9550-Day RangeC$7.01▼C$12.0052-Week RangeC$5.10▼C$15.00Volume7,648 shsAverage Volume1,656 shsMarket CapitalizationC$24.89 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Devonian Health Group Inc. engages in the development of botanical drugs. Its lead product candidate is Thykamine, completed Phase IIa clinical trial product for the treatment of ulcerative colitis and atopic dermatitis. The company also develops Pantoprazole Magnesium for the treatment of gastric; Cleo-35 for the treatment of hormonal acne in women; and value-added products for dermo-cosmetics. In addition, the company acquires drug and health product licenses; and distributes pharmaceutical products. Devonian Health Group Inc. was incorporated in 2015 and is headquartered in Québec, Canada. Read More Receive GSD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Devonian Health Group and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. GSD Stock News HeadlinesDevonian Health Group Inc. Anticipates to Commence Trading on the NYSE AmericanSeptember 11, 2026 | finance.yahoo.comDevonian Tightens Thykamine Quality Controls with Validated Chemical and Biological AssaysSeptember 2, 2026 | theglobeandmail.comShocking new footage just releasedGerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he says has never existed before. In a similar setup in the past, select investors saw $1,000 turn into over $1 million within a few years. Del Real just released a full video breakdown of what is driving this move and how to prepare. | Digest Publishing (Ad)Devonian Health Group Strengthens Thykamine™ Manufacturing Platform with Validated Chemical-Composition Fingerprinting and Biological Potency AssaySeptember 2, 2026 | finance.yahoo.comDevonian Health Group Inc.: Devonian Health Group Anticipates to Commence Trading on the NYSE AmericanAugust 18, 2026 | finanznachrichten.deDevonian Health Group Anticipates to Commence Trading on the NYSE AmericanAugust 18, 2026 | finance.yahoo.comDevonian Health Group Plans NYSE American Listing to Boost Market VisibilityAugust 18, 2026 | tipranks.comDevonian Health Group Inc.: Devonian Health Group Announces Proposed Listing on the NYSE American with Concurrent Underwritten Public OfferingJuly 28, 2026 | finanznachrichten.deSee More Headlines GSD Stock Analysis - Frequently Asked Questions How have GSD shares performed this year? Devonian Health Group's stock was trading at C$11.40 at the beginning of 2026. Since then, GSD stock has decreased by 21.5% and is now trading at C$8.95. When did Devonian Health Group's stock split? Devonian Health Group shares reverse split on Thursday, January 22nd 2026.The 1-60 reverse split was announced on Thursday, January 22nd 2026. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, January 22nd 2026. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split. How do I buy shares of Devonian Health Group? Shares of GSD stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. Industry, Sector and Symbol Stock ExchangeCVE SectorTechnology Industry Software Sub-IndustryApplication Software Current SymbolCVE:GSD CIKN/A Webwww.groupedevonian.com Phone450-937-6696FaxN/AEmployees6Year FoundedN/AProfitability EPS (Trailing Twelve Months)C($2.25) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-C$3.17 million Net Margins-32.50% Pretax MarginN/A Return on Equity-23.31% Return on Assets-8.12% Debt Debt-to-Equity Ratio16.36 Current Ratio1.07 Quick Ratio7.82 Sales & Book Value Annual SalesC$3.00 million Price / Sales8.31 Cash FlowC$1.47 per share Price / Cash Flow6.10 Book ValueC$0.09 per share Price / Book99.44Miscellaneous Outstanding Shares2,781,000Free FloatN/AMarket CapC$24.89 million OptionableNot Optionable Beta0.03 The 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (CVE:GSD) was last updated on 9/24/2026 by MarketBeat.com Staff. From Our PartnersHow to get a stake in Anthropic — before the IPOAnthropic, the maker of Claude AI, has reportedly filed for an IPO that could arrive as early as October. Its ...Weiss Ratings | SponsoredShocking new footage just releasedGerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...Digest Publishing | SponsoredMajor Buy Alert Issued for September 30thKeith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ...TradeSmith | SponsoredIf you keep cash in a U.S. bank account… read this NOWSince 2020, U.S. banks have been required to keep zero percent of deposits on hand, lending out nearly every d...Banyan Hill Publishing | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredOn October 7th, your “safest” assets are at riskJeff Brown called Nvidia's rise of over 27,000 percent and warned in early 2024 that inflation would outlast W...Brownstone Research | SponsoredWhile SpaceX Gets the Spotlight, FJET Is Building What Comes Next!Starfighters Space (NYSE: FJET) operates the world's only commercial fleet of flight-ready Mach 2+ F-104 Starf...Trading Wire | SponsoredThey're shrinking your dollars every single monthSince 2020, the dollar has lost roughly a quarter of its buying power. A $500,000 nest egg today buys about wh...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Devonian Health Group Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Devonian Health Group With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
